Merck’s iLab53 (a modular 39-foot mobile unit) was used to bring clinical research into community settings as an effort to increase clinical trial awareness and engagement.

More specifically:

How the iLab53 was created and implemented

How Merck is continuing to work to help build trust within communities, and provide increased access to clinical research

Challenges, learnings and successes to date

How this initiative can be scaled and adapted

Susan Manoff, MD, MPH, Executive Director, Office of the Chief Patient Officer, Merck

Kai Bode, Director, Digital Innovation and Patient Strategy, Global Digital Analytics & Technologies Team, Merck

Learn more about the Patients as Partners in Clinical Research conference at www.patientsaspartners.org